FDA Clearance Tracker · P150004-S069
Axium Neurostimulator System
Last checked: Nov 20, 2026Latest source record: Oct 8, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 8, 2024
Approved
Time to decision
229 days
Received Feb 22, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150004-S069
- Device name
- Axium Neurostimulator System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plano, TX
- Received
- Feb 22, 2024
- Decided
- Oct 8, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P150004
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the addition of an alternate ethylene oxide (EO) sterilization site, Centerpiece Sterilization Corporation Cycle ABB-059-R, located in Tijuana, Mexico, for the following products:1) Abbott Medical Spinal Cord Stimulation (SCS) Systems: Family of Proclaim, Proclaim XR & Proclaim Plus IPGs; Protégé MRI & Protégé IPGs; Prodigy MRI & Prodigy IPGs; Eon Mini IPG; Eterna SCS IPG Associated SCS leads, extensions and accessories 2) Abbott Medical Deep Brain Stimulation Systems Family of Infinity DBS IPGs; Liberta DBS IPG Associated DBS leads, extensions and accessories 3) Abbott Medical dorsal root ganglion stimulation system: Proclaim DRG IPG Associated DRG leads, extensions and accessories
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.